Inici › Càncer de pròstata › Washington › Tacoma
Assaigs clínics de Càncer de pròstata a Tacoma, WA
11 estudis de Càncer de pròstata busquen participants en centres de Tacoma i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Providence Regional Cancer System-Lacey, Lacey · a 23 mi
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
ReclutantFase 3
- Northwest Medical Specialties, PLLC, Tacoma
- Northwest Medical Specialties, PLLC, Gig Harbor · a 8 mi
- Northwest Medical Specialties, PLLC, Puyallup · a 8 mi
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ReclutantFase 3
- Northwest Medical Specialties, PLLC, Tacoma
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ReclutantFase 3
- Northwest Medical Specialties, Tacoma
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutantVoluntaris sans benvinguts
- Madigan Army Medical Center, Tacoma
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
ReclutantFase 3
- Research Site, Tacoma
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutantFase 3
- Providence Regional Cancer System-Lacey, Lacey · a 23 mi
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ReclutantFase 2
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutantFase 3
- Providence Regional Cancer System-Lacey, Lacey · a 23 mi
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
ReclutantFase 1
- Northwest Medical Specialties, Tacoma
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
ReclutantFase 2
- Providence Regional Cancer System-Yelm, Yelm · a 23 mi
- Providence Regional Cancer System-Lacey, Lacey · a 23 mi
Assaigs de Càncer de pròstata en altres ciutats
- New York City, NY103 estudis
- Houston, TX76 estudis
- Los Angeles, CA61 estudis
- Boston, MA59 estudis
- St. Louis, MO46 estudis
- Chicago, IL45 estudis
- San Francisco, CA45 estudis
- Philadelphia, PA44 estudis
- Baltimore, MD43 estudis
- Nashville, TN42 estudis
- Seattle, WA42 estudis
- Washington, DC38 estudis
Altres estudis a Tacoma
- Càncer de pulmó de cèl·lules no petites20 estudis
- Càncer de mama18 estudis
- Colitis ulcerosa15 estudis
- Mieloma múltiple13 estudis
- Malaltia de Crohn11 estudis
- Càncer metastàtic9 estudis
- Càncer colorrectal9 estudis
- Melanoma7 estudis
- Càncer d'ovari7 estudis
- Càncer (tots els tipus)6 estudis
- Càncer de pàncrees6 estudis
- Obesitat6 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.